1. Home
  2. EVAX vs AMST Comparison

EVAX vs AMST Comparison

Compare EVAX & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • AMST
  • Stock Information
  • Founded
  • EVAX 2008
  • AMST 2017
  • Country
  • EVAX Denmark
  • AMST United States
  • Employees
  • EVAX N/A
  • AMST N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • AMST Computer Software: Prepackaged Software
  • Sector
  • EVAX Health Care
  • AMST Technology
  • Exchange
  • EVAX Nasdaq
  • AMST Nasdaq
  • Market Cap
  • EVAX 8.7M
  • AMST 7.4M
  • IPO Year
  • EVAX 2021
  • AMST 2020
  • Fundamental
  • Price
  • EVAX $2.49
  • AMST $3.30
  • Analyst Decision
  • EVAX Strong Buy
  • AMST
  • Analyst Count
  • EVAX 3
  • AMST 0
  • Target Price
  • EVAX $33.33
  • AMST N/A
  • AVG Volume (30 Days)
  • EVAX 6.9M
  • AMST 31.9K
  • Earning Date
  • EVAX 03-26-2025
  • AMST 02-10-2025
  • Dividend Yield
  • EVAX N/A
  • AMST N/A
  • EPS Growth
  • EVAX N/A
  • AMST N/A
  • EPS
  • EVAX N/A
  • AMST N/A
  • Revenue
  • EVAX $3,295,000.00
  • AMST $86,115.00
  • Revenue This Year
  • EVAX $9,039.73
  • AMST N/A
  • Revenue Next Year
  • EVAX $1.47
  • AMST N/A
  • P/E Ratio
  • EVAX N/A
  • AMST N/A
  • Revenue Growth
  • EVAX N/A
  • AMST N/A
  • 52 Week Low
  • EVAX $2.22
  • AMST $1.85
  • 52 Week High
  • EVAX $22.50
  • AMST $6.27
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 39.85
  • AMST 45.99
  • Support Level
  • EVAX $2.30
  • AMST $3.16
  • Resistance Level
  • EVAX $2.80
  • AMST $3.60
  • Average True Range (ATR)
  • EVAX 0.51
  • AMST 0.20
  • MACD
  • EVAX 0.03
  • AMST 0.00
  • Stochastic Oscillator
  • EVAX 6.97
  • AMST 33.03

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

Share on Social Networks: